Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 27, 2016 - Issue 5
Submit an article Journal homepage
1,065
Views
24
CrossRef citations to date
0
Altmetric
Psoriasis

Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review

Tian Hao ZhuUniversity of Southern California Keck School of Medicine, Los Angeles, CA, USA, Correspondence[email protected]
,
Mio NakamuraDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA, USA,
,
Michael AbroukUniversity of California Irvine School of Medicine, Irvine, CA, USA, and
,
Benjamin FarahnikUniversity of Vermont College of Medicine, Burlington, VT, USA
,
John KooDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA, USA,
&
Tina BhutaniDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California San Francisco, San Francisco, CA, USA,
Pages 406-413 | Received 12 Nov 2015, Accepted 20 Dec 2015, Published online: 02 Feb 2016

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Issam Hamadah & Muzamil A. Chisti. (2022) Axonal sensorimotor polyneuropathy after starting guselkumab. Journal of Dermatological Treatment 33:4, pages 2371-2372.
Read now
J. M. Carrascosa & E. Del-Alcazar. (2018) New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management. Expert Review of Clinical Immunology 14:4, pages 259-273.
Read now
Buraa Kubaisi, Sarah Syeda, Alexander Schmidt & C. Stephen Foster. (2017) Adalimumab for the treatment of non-infectious uveitis: an updated review. Expert Opinion on Orphan Drugs 5:2, pages 201-206.
Read now

Articles from other publishers (21)

Masahide Funabiki, Masayuki Tahara, Seiko Kondo, Naho Ayuzawa & Hidetoshi Yanagida. (2023) SAPHO Syndrome Complicated by Lesions of the Central Nervous System Successfully Treated with Brodalumab. Case Reports in Rheumatology 2023, pages 1-5.
Crossref
Jessica Larson, Patrick Twohig & Kathryn Hutchins. (2023) Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar. ACG Case Reports Journal 10:2, pages e00993.
Crossref
I. Tekin & F. Kosova. (2022) The level pro-inflammatory and anti-inflammatory biomarkers in patients with chronic mechanical low back pain under pulse radiofrequency therapy. The Ukrainian Biochemical Journal 94:3, pages 59-67.
Crossref
Carlyn V. Kouwenberg, Viera Koopman‐Kalinina Ayuso & Joke H. de Boer. (2021) Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis. Acta Ophthalmologica 100:4.
Crossref
Isabelle Williams, Sumeet Pandey, Wolfram Haller, Hien Quoc Huynh, Alicia Chan, Gesche Düeker, Ruth Bettels, Laurent Peyrin-Biroulet, Chinenye R. Dike, Catherine DeGeeter, David Smith, Nada Al Eisa, Nick Platt, Thorsten Marquardt, Tobias Schwerd, Frances M. Platt & Holm H. Uhlig. (2022) Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C. Wellcome Open Research 7, pages 11.
Crossref
Maryam Zahid, Alberto Busmail, Sai Sri Penumetcha, Saher Ahluwalia, Rejja Irfan, Sawleha Arshi Khan, Sai Rohit Reddy, Maria Elisa Vasquez Lopez & Lubna Mohammed. (2021) Tumor Necrosis Factor Alpha Blockade and Multiple Sclerosis: Exploring New Avenues. Cureus.
Crossref
Amy W. YuMaggie PecsokErin E. LongbrakeSarah F. Wesley. (2021) Neuroinflammation Associated With Tumor Necrosis Factor-α Inhibitor Exposure. Neurology Clinical Practice 11:4.
Crossref
Eugeniusz Józef Kucharz & Anna Kotulska-Kucharz. (2021) Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?. Reumatologia/Rheumatology 59:2, pages 65-67.
Crossref
Simeng Lin, Harry D Green, Peter Hendy, Neel M Heerasing, Neil Chanchlani, Benjamin Hamilton, Gareth J Walker, Graham A Heap, Jeremy Hobart, Roswell J Martin, Alasdair J Coles, Mark S Silverberg, Peter M Irving, Guy Chung-Faye, Eli Silber, J R Fraser Cummings, Ellina Lytvyak, Vibeke Andersen, Andrew R Wood, Jessica Tyrrell, Robin N Beaumont, Michael N Weedon, Nicholas A Kennedy, Alexander Spiers, Timothy Harrower, James R Goodhand & Tariq Ahmad. (2020) Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment. Journal of Crohn's and Colitis 14:12, pages 1653-1661.
Crossref
Amy Kunchok, Allen J. AksamitJrJr, John M. DavisIIIIII, Orhun H. Kantarci, B. Mark Keegan, Sean J. Pittock, Brian G. Weinshenker & Andrew McKeon. (2020) Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events. JAMA Neurology 77:8, pages 937.
Crossref
Afshin Borhani-Haghighi, Bahareh Kardeh, Shubhasree Banerjee, Golnaz Yadollahikhales, Anahid Safari, Mohammad Ali Sahraian & Lee Shapiro. (2020) Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment. Multiple Sclerosis and Related Disorders 39, pages 101906.
Crossref
Mahyar Etminan, Mohit Sodhi, Ali Samii, Bruce C Carleton, Abbas Kezouh & J Antonio Avina-Zubieta. (2019) Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases. Seminars in Arthritis and Rheumatism 48:6, pages 1083-1086.
Crossref
David V. Gauvin, Zachary J. Zimmermann & Theodore J. Baird. (2019) In further defense of nonclinical abuse liability testing of biologics. Regulatory Toxicology and Pharmacology 101, pages 103-120.
Crossref
Anne G. Osborn & Michael Scheel. 2019. Osborn's Brain. Osborn's Brain 411 448 .
S. Adamo, J. Nilsson, A. Krebs, U. Steiner, A. Cozzio, L.E. French & A.G.A. Kolios. (2018) Successful treatment of SAPHO syndrome with apremilast. British Journal of Dermatology 179:4, pages 959-962.
Crossref
J. M. E. Boggs & L. Barnes. (2018) Demyelination during anti-tumour necrosis factor therapy for psoriasis. Clinical and Experimental Dermatology 43:5, pages 577-578.
Crossref
Sandra C. Signore, Birka Brauns, Gunther Schütze, Christoph P. Dohm, Mathias Bähr, Rotraut Mössner & Pawel Kermer. (2018) Infliximab-Associated Chronic Inflammatory Central Nervous System Disease and Peroneal Nerve Injury in a Psoriatic Patient Refractory to Treatment: Case Report with 10-Year Follow-Up. Case Reports in Neurology 10:1, pages 12-17.
Crossref
Judith Günther & Uwe Fricke. 2018. Arzneiverordnungs-Report 2018. Arzneiverordnungs-Report 2018 481 524 .
Sahil Sekhon, Caleb Jeon & Wilson Liao. 2018. Evidence-Based Psoriasis. Evidence-Based Psoriasis 73 92 .
Norman Saffra & Konstantin Astafurov. (2017) Visual Loss Induced by Adalimumab Used for Plaque Psoriasis. Case Reports in Dermatology 9:1, pages 60-64.
Crossref
Judith Günther & Uwe Fricke. 2017. Arzneiverordnungs-Report 2017. Arzneiverordnungs-Report 2017 431 476 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.